Urocortin 2 increases c-Fos expression in topographically organized subpopulations of serotonergic neurons in the rat dorsal raphe nucleus

Brain Research

Volumn 1044, Issue 2, 2005, Pages 176-189

  Staub, Daniel R ^a   Spiga, Francesca ^a   Lowry, Christopher A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

CRF2 receptor; Dorsal raphe nucleus; Serotonin; Urocortin 2

Indexed keywords

PROTEIN C FOS; SEROTONIN; TRYPTOPHAN HYDROXYLASE; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN 2;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN REGION; CELL SUBPOPULATION; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; ESCAPE BEHAVIOR; FEAR; IMMUNOHISTOCHEMISTRY; LEARNED HELPLESSNESS; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; TOPOGRAPHY;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN MAPPING; CELL COUNT; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; RANDOM ALLOCATION; RAPHE NUCLEI; RATS; RATS, WISTAR; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

EID: 18844408033     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2005.02.080     Document Type: Article

References (42)

1. J.K. Abrams, P.L. Johnson, J.H. Hollis, and C.A. Lowry Anatomic and functional topography of the dorsal raphe nucleus Ann. N. Y. Acad. Sci. 1018 2004 46 57
2. J. Amat, J.P. Tamblyn, E.D. Paul, S.T. Bland, P. Amat, A.C. Foster, L.R. Watkins, and S.F. Maier Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala Neuroscience 129 2004 509 519
3. C.D. Balaban, and J.F. Thayer Neurological bases for balance-anxiety links J. Anxiety Disord. 15 2001 53 79
4. T.L. Bale, and W.W. Vale CRF and CRF receptors: role in stress responsivity and other behaviors Annu. Rev. Pharmacol. Toxicol. 44 2004 525 557
5. R.J. Blanchard, and D.C. Blanchard Attack and defense in rodents as ethoexperimental models for the study of emotion Prog. Neuro-Psychopharmacol. Biol. Psychiatry 13 1989 S3 S14 (Suppl.)
6. D.C. Blanchard, G. Griebel, and R.J. Blanchard Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic Neurosci. Biobehav. Rev. 25 2001 205 218
7. D.T. Chalmers, T.W. Lovenberg, and E.B. De Souza Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression J. Neurosci. 15 1995 6340 6350
8. A.M. Chen, M.H. Perrin, M.R. Digruccio, J.M. Vaughan, B.K. Brar, C.M. Arias, K.A. Lewis, J.E. Rivier, P.E. Sawchenko, and W.W. Vale A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity Proc. Natl. Acad. Sci. U. S. A. 102 2005 2620 2625
9. K.G. Commons, K.R. Connolley, and R.J. Valentino A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders Neuropsychopharmacology 28 2003 206 215
10. F.M. Dautzenberg, G.J. Kilpatrick, R.L. Hauger, and J. Moreau Molecular biology of the CRH receptors-in the mood Peptides 22 2001 753 760
11. H.E. Day, B.N. Greenwood, S.E. Hammack, L.R. Watkins, M. Fleshner, S.F. Maier, and S. Campeau Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus J. Comp. Neurol. 474 2004 364 378
12. R.E. Grahn, M.J. Will, S.E. Hammack, S. Maswood, M.B. McQueen, L.R. Watkins, and S.F. Maier Activation of serotonin-immunoreactive cells in the dorsal raphe nucleus in rats exposed to an uncontrollable stressor Brain Res. 826 1999 35 43
13. S.E. Hammack, K.J. Richey, M.J. Schmid, M.L. LoPresti, L.R. Watkins, and S.F. Maier The role of corticotropin-releasing hormone in the dorsal raphe nucleus in mediating the behavioral consequences of uncontrollable stress J. Neurosci. 22 2002 1020 1026
14. S.E. Hammack, J.L. Pepin, J.S. DesMarteau, L.R. Watkins, and S.F. Maier Low doses of corticotropin-releasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress Behav. Brain Res. 147 2003 55 64
15. S.E. Hammack, M.J. Schmid, M.L. LoPresti, A. Der-Avakian, M.A. Pellymounter, A.C. Foster, L.R. Watkins, and S.F. Maier Corticotropin releasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress J. Neurosci. 23 2003 1019 1025
16. K. Inoue, G.R. Valdez, T.M. Reyes, L.E. Reinhardt, A. Tabarin, J. Rivier, W.W. Vale, P.E. Sawchenko, G.F. Koob, and E.P. Zorrilla Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat J. Pharmacol. Exp. Ther. 305 2003 385 393
17. B.L. Jacobs, and E.C. Azmitia Structure and function of the brain serotonin system Physiol. Rev. 72 1992 165 229
18. O. Jahn, H. Tezval, L. van Werven, K. Eckart, and J. Spiess Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity Neuropharmacology 47 2004 233 242
19. L.G. Kirby, K.C. Rice, and R.J. Valentino Effects of corticotropin- releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus Neuropsychopharmacology 22 2000 148 162
20. S.F. Leibowitz, and J.T. Alexander Hypothalamic serotonin in control of eating behavior, meal size, and body weight Biol. Psychiatry 44 1998 851 864
21. K. Lewis, C. Li, M.H. Perrin, A. Blount, K. Kunitake, C. Donaldson, J. Vaughan, T.M. Reyes, J. Gulyas, W. Fischer, L. Bilezikjian, J. Rivier, P.E. Sawchenko, and W.W. Vale Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor Proc. Natl. Acad. Sci. U. S. A. 98 2001 7570 7575
22. A.D. Loewy Forebrain nuclei involved in autonomic control Prog. Brain Res. 87 1991 253 268
23. C.A. Lowry Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis J. Neuroendocrinol. 14 2002 911 923
24. C.A. Lowry, J.E. Rodda, S.L. Lightman, and C.D. Ingram Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system J. Neurosci. 20 2000 7728 7736
25. S.F. Maier, and L.R. Watkins Stressor controllability, anxiety, and serotonin Cognitive Ther. Res. 22 1998 595 613
26. M.J. Millan The neurobiology and control of anxious states Prog. Neurobiol. 70 2003 83 244
27. J.I. Morgan, and T. Curran Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun Annu. Rev. Neurosci. 14 1991 421 451
28. H. Ohata, and T. Shibasaki Effects of urocortin 2 and 3 on motor activity and food intake in rats Peptides 25 2004 1703 1709
29. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates Fourth Edition 1998 Academic Press San Diego
30. M.A. Pelleymounter, M. Joppa, N. Ling, and A.C. Foster Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress J. Pharmacol. Exp. Ther. 302 2002 145 152
31. M.A. Pelleymounter, M. Joppa, N. Ling, and A.C. Foster Behavioral and neuroendocrine effects of the selective CRF2 receptor agonists urocortin II and urocortin III Peptides 25 2004 659 666
32. L. Pernar, A.L. Curtis, W.W. Vale, J.E. Rivier, and R.J. Valentino Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions J. Neurosci. 24 2004 1305 1311
33. T. Petrov, T.L. Krukoff, and J.H. Jhamandas The hypothalamic paraventricular and lateral parabrachial nuclei receive collaterals from raphe nucleus neurons: a combined double retrograde and immunocytochemical study J. Comp. Neurol. 318 1992 18 26
34. T.M. Reyes, K. Lewis, M.H. Perrin, K.S. Kunitake, J. Vaughan, C.A. Arias, J.B. Hogenesch, J. Gulyas, J. Rivier, W.W. Vale, and P.E. Sawchenko Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors Proc. Natl. Acad. Sci. U. S. A. 98 2001 2843 2848
35. L.K. Takahashi, S.P. Ho, V. Livanov, N. Graciani, and S.P. Arneric Antagonism of CRF2 receptors produces anxiolytic behavior in animal models of anxiety Brain Res. 902 2001 135 142
36. M.A. Ungless, V. Singh, T.L. Crowder, R. Yaka, D. Ron, and A. Bonci Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons Neuron 39 2003 401 407
37. G.R. Valdez, K. Inoue, G.F. Koob, J. Rivier, W. Vale, and E.P. Zorrilla Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide Brain Res. 943 2002 142 150
38. G.R. Valdez, E.P. Zorrilla, J. Rivier, W.W. Vale, and G.F. Koob Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist Brain Res. 980 2003 206 212
39. M.W. Vasey, and J.F. Thayer The continuing problem of false positives in repeated measures ANOVA in psychophysiology: a multivariate solution Psychophysiology 24 1987 479 486
40. J. Vaughan, C. Donaldson, J. Bittencourt, M.H. Perrin, K. Lewis, S. Sutton, R. Chan, A.V. Turnbull, D. Lovejoy, and C. Rivier Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor Nature 378 1995 287 292
41. M. Venihaki, S. Sakihara, S. Subramanian, P. Dikkes, S.C. Weninger, G. Liapakis, T. Graf, and J.A. Majzoub Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behaviours J. Neuroendocrinol. 16 2004 411 422
42. E.P. Zorrilla, L.E. Reinhardt, G.R. Valdez, K. Inoue, J.E. Rivier, W.W. Vale, and G.F. Koob Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity J. Pharmacol. Exp. Ther. 310 2004 1027 1034